Lilly Rips Page From Big Pharma Playbook: Reorganize, Cut Costs
This article was originally published in The Pink Sheet Daily
Executive Summary
Cost reduction plan is aimed at saving $1 billion by the end of 2010 ahead of the patent expiration of Zyprexa.